Cargando…

Understanding metabolic flexibility: a potential key to unlocking metabolic therapies in amyotrophic lateral sclerosis?

Detalles Bibliográficos
Autor principal:	Allen, Scott P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437589/ https://www.ncbi.nlm.nih.gov/pubmed/32209766 http://dx.doi.org/10.4103/1673-5374.276333

Ejemplares similares

Glucose metabolism in amyotrophic lateral sclerosis: it is bitter-sweet
por: Lerskiatiphanich, Titaya, et al.
Publicado: (2022)

TDP-43—The key to understanding amyotrophic lateral sclerosis
por: Xu, Zuoshang, et al.
Publicado: (2014)

Dermic-derived fibroblasts for the study of amyotrophic lateral sclerosis
por: Riancho, Javier, et al.
Publicado: (2020)

Glaucoma and amyotrophic lateral sclerosis, two kindred diseases?
por: Carreras, Francisco Javier
Publicado: (2016)

Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments
por: Tefera, Tesfaye W., et al.
Publicado: (2017)

Metabolic Reprogramming in Amyotrophic Lateral Sclerosis
por: Szelechowski, M., et al.
Publicado: (2018)

Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis
por: Kirk, Siobhan E., et al.
Publicado: (2019)

Why TDP-43? Why Not? Mechanisms of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis
por: Floare, Mara-Luciana, et al.
Publicado: (2020)

C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis
por: Allen, Scott P, et al.
Publicado: (2019)

Complement: a global immunometabolic regulator in amyotrophic lateral sclerosis
por: Lo, Martin W., et al.
Publicado: (2020)

Fibrosis as a common trait in amyotrophic lateral sclerosis tissues
por: Apolloni, Savina, et al.
Publicado: (2021)

Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis
por: Li, Jin‐Yue, et al.
Publicado: (2022)

P2X7 receptor antagonism in amyotrophic lateral sclerosis
por: Sluyter, Ronald, et al.
Publicado: (2017)

Amyotrophic lateral sclerosis disease burden: doing better at getting better
por: Volonté, Cinzia, et al.
Publicado: (2022)

Altered RNA metabolism and amyotrophic lateral sclerosis
por: Verma, Ashok
Publicado: (2011)

Defective cholesterol metabolism in amyotrophic lateral sclerosis
por: Abdel-Khalik, Jonas, et al.
Publicado: (2017)

Amyotrophic lateral sclerosis alters the metabolic aging profile in patient derived fibroblasts
por: Gerou, Margarita, et al.
Publicado: (2021)

Autologous bone marrow mononuclear cells as neuroprotective treatment of amyotrophic lateral sclerosis
por: Ruiz-López, Francisco José, et al.
Publicado: (2016)

Amyotrophic lateral sclerosis disease modifying therapeutics: a cell biological perspective
por: Tang, Bor Luen
Publicado: (2017)

Amyotrophic lateral sclerosis, a neurodegenerative motor neuron disease with retinal involvement
por: Ramírez, Ana I., et al.
Publicado: (2021)

Phenotypic heterogeneity in amyotrophic lateral sclerosis type 8 and modifying mechanisms of neurodegeneration
por: Oliveira, Danyllo, et al.
Publicado: (2021)

The important functional role of TDP-43 plays in amyotrophic lateral sclerosis-frontotemporal dementia
por: Chen, Liam
Publicado: (2020)

Mending the broken in amyotrophic lateral sclerosis: DNA damage and repair in motor neuron degeneration
por: Kim, Byung Woo, et al.
Publicado: (2020)

State-of-art modelling of inflammatory astrocyte-synapse interactions in injury and amyotrophic lateral sclerosis
por: Lakatos, András
Publicado: (2017)

Novel small molecule TRVA242 targets neuromuscular junction in amyotrophic lateral sclerosis
por: Bose, Poulomee
Publicado: (2019)

Ubiquitin homeostasis disruption, a common cause of proteostasis collapse in amyotrophic lateral sclerosis?
por: Chisholm, Christen G., et al.
Publicado: (2022)

Recent advances in understanding amyotrophic lateral sclerosis and emerging therapies
por: Gittings, Lauren M, et al.
Publicado: (2020)

Adipose-derived stem cell conditioned medium for the treatment of amyotrophic lateral sclerosis: pre-clinical evidence and potential for clinical application
por: Walker, Chandler L.
Publicado: (2019)

Degenerative and regenerative processes in amyotrophic lateral sclerosis: motor reserve, adaptation and putative compensatory changes
por: Bede, Peter, et al.
Publicado: (2020)

Combination of novel RNA sequencing and sophisticated network modeling to reveal a common denominator in amyotrophic lateral sclerosis?
por: Dash, Banaja P., et al.
Publicado: (2023)

Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis
por: Canosa, Antonio, et al.
Publicado: (2020)

The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients
por: Zeng, Qianqian, et al.
Publicado: (2020)

Isotopic Evidence for Disrupted Copper Metabolism in Amyotrophic Lateral Sclerosis
por: Sauzéat, Lucie, et al.
Publicado: (2018)

Energy Homeostasis and Abnormal RNA Metabolism in Amyotrophic Lateral Sclerosis
por: Liu, Yu-Ju, et al.
Publicado: (2017)

Altered Metabolic Profiles of the Plasma of Patients with Amyotrophic Lateral Sclerosis
por: Chang, Kuo-Hsuan, et al.
Publicado: (2021)

Chemically oligomerizable TDP-43: a novel chemogenetic tool for studying the pathophysiology of amyotrophic lateral sclerosis
por: Kanekura, Kohsuke, et al.
Publicado: (2022)

Antiretroviral Therapy and Dyslipidaemia: Unlocking the Code
por: Mallon, Patrick W. G
Publicado: (2006)

Genetic Analysis of Tryptophan Metabolism Genes in Sporadic Amyotrophic Lateral Sclerosis
por: Fifita, Jennifer A., et al.
Publicado: (2021)

Unlocking complex soil systems as carbon sinks: multi-pool management as the key
por: Angst, Gerrit, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_16dan860rf2m48tvfp53p1843r